{"id":757,"count":10,"description":"<div class=\"msf-hero\">\r\n<div class=\"msf-threat-badge high\">Cross-Border Medical Marketing \u2014 EU-Wide Risk<\/div>\r\n<h1>European Medical Marketing Compliance: The Rules, Country by Country<\/h1>\r\n<p>A practical hub for clinic owners, aesthetic and dental practices, and the agencies that market them across Europe. Medical advertising law is national, fragmented, and enforced locally \u2014 a phrase that is routine in one country can trigger fines in another. This hub explains the risk and points you to the exact rules for each market you advertise into.<\/p>\r\n\r\n<div class=\"msf-hero-facts\">\r\n<div class=\"msf-hero-fact\">\r\n<div class=\"fact-number\">10<\/div>\r\n<div class=\"fact-label\">Country guides live \u2014 Germany, Austria, Switzerland, France, Belgium, Netherlands, Hungary, Poland, Romania, UK<\/div>\r\n<\/div>\r\n<div class=\"msf-hero-fact\">\r\n<div class=\"fact-number\">10%<\/div>\r\n<div class=\"fact-label\">Of global turnover \u2014 the ceiling on direct fines in the strictest markets (UK CMA, Poland UOKiK)<\/div>\r\n<\/div>\r\n<div class=\"msf-hero-fact\">\r\n<div class=\"fact-number\">1 post<\/div>\r\n<div class=\"fact-label\">Is enough \u2014 a single cross-border ad can breach several national frameworks at once<\/div>\r\n<\/div>\r\n<\/div>\r\n<\/div>\r\n<!-- ========== WHAT THIS HUB IS ========== -->\r\n<h2>What you'll find here<\/h2>\r\nEach country guide below covers the same practical ground for one market: the phrases that get clinics reported or fined, the trigger words in the local language, what you can safely rewrite them to, the grey areas that need judgement, and who enforces the rules. The guides are written for marketers, not lawyers \u2014 plain-language risk guidance, not legal certification.\r\n\r\nThe single most misunderstood point in European clinic marketing: <strong>you comply with the law of the market you advertise into, not the country your clinic sits in.<\/strong> A Budapest clinic running German-language ads for German patients answers to Germany's HWG \u2014 not Hungarian law. This hub exists to make that visible before it costs you.\r\n\r\n<!-- ========== HOW TO USE IT ========== -->\r\n<h2>How to use this hub<\/h2>\r\n<ul class=\"msf-key-points\">\r\n \t<li>Advertising into one country? Open that country's guide and work through its red \/ yellow \/ green tables.<\/li>\r\n \t<li>Running cross-border campaigns? Read the guide for every destination market \u2014 not just where your clinic is based.<\/li>\r\n \t<li>Translating existing content into another language? The destination market's rules apply to the translated version.<\/li>\r\n<\/ul>\r\n<!-- ========== COUNTRY GUIDE GRID ========== -->\r\n<h2>Compliance guides by country<\/h2>\r\n<table class=\"msf-table\">\r\n<thead>\r\n<tr>\r\n<th>Market<\/th>\r\n<th>Risk level<\/th>\r\n<th>What bites most often<\/th>\r\n<th>Guide<\/th>\r\n<\/tr>\r\n<\/thead>\r\n<tbody>\r\n<tr>\r\n<td><strong>\ud83c\udde9\ud83c\uddea Germany<\/strong><\/td>\r\n<td>High<\/td>\r\n<td>Strictest in the EU \u2014 blanket before\/after ban, now extended to filler procedures and organic social posts (HWG).<\/td>\r\n<td><a href=\"\/medical-compliance\/germany-medical-advertising\/\">Germany rules \u2192<\/a><\/td>\r\n<\/tr>\r\n<tr>\r\n<td><strong>\ud83c\udde6\ud83c\uddf9 Austria<\/strong><\/td>\r\n<td>Medium-High<\/td>\r\n<td>Three frameworks stack (\u00c4rzteG, \u00c4sthOpG, UWG); price-promotional language for procedures is fined.<\/td>\r\n<td><a href=\"\/medical-compliance\/austria-medical-advertising\/\">Austria rules \u2192<\/a><\/td>\r\n<\/tr>\r\n<tr>\r\n<td><strong>\ud83c\udde8\ud83c\udded Switzerland<\/strong><\/td>\r\n<td>Medium<\/td>\r\n<td>Cantonal variation on top of MedBG + FMH code; before\/after restricted (explicit ban in Geneva for botulinum toxin).<\/td>\r\n<td><a href=\"\/medical-compliance\/switzerland-medical-advertising\/\">Switzerland rules \u2192<\/a><\/td>\r\n<\/tr>\r\n<tr>\r\n<td><strong>\ud83c\uddeb\ud83c\uddf7 France<\/strong><\/td>\r\n<td>High (aesthetics)<\/td>\r\n<td>Absolute ban on influencer promotion of aesthetic acts (Loi 2023-451); dedicated DGCCRF enforcement brigade.<\/td>\r\n<td><a href=\"\/medical-compliance\/france-medical-advertising\/\">France rules \u2192<\/a><\/td>\r\n<\/tr>\r\n<tr>\r\n<td><strong>\ud83c\udde7\ud83c\uddea Belgium<\/strong><\/td>\r\n<td>High (aesthetics)<\/td>\r\n<td>Near-total advertising prohibition for aesthetic medicine \u2014 only factual, objective, discreet information is permitted.<\/td>\r\n<td><a href=\"\/medical-compliance\/belgium-medical-advertising\/\">Belgium rules \u2192<\/a><\/td>\r\n<\/tr>\r\n<tr>\r\n<td><strong>\ud83c\uddf3\ud83c\uddf1 Netherlands<\/strong><\/td>\r\n<td>Medium-High<\/td>\r\n<td>Price-promotion prohibition (CCBA); advertising injectables escalates you into Wet BIG public-health analysis.<\/td>\r\n<td><a href=\"\/medical-compliance\/netherlands-medical-advertising\/\">Netherlands rules \u2192<\/a><\/td>\r\n<\/tr>\r\n<tr>\r\n<td><strong>\ud83c\udded\ud83c\uddfa Hungary<\/strong><\/td>\r\n<td>Medium-High (outbound)<\/td>\r\n<td>One post can breach four statutes at once; highest exposure is cross-border ads aimed at German-speaking patients.<\/td>\r\n<td><a href=\"\/medical-compliance\/hungary-medical-advertising\/\">Hungary rules \u2192<\/a><\/td>\r\n<\/tr>\r\n<tr>\r\n<td><strong>\ud83c\uddf5\ud83c\uddf1 Poland<\/strong><\/td>\r\n<td>High (clinic-level)<\/td>\r\n<td>Dual-layer system: statutory entity-level ad ban + KEL 2025 ethics code; UOKiK fines up to 10% of turnover.<\/td>\r\n<td><a href=\"\/medical-compliance\/poland-medical-advertising\/\">Poland rules \u2192<\/a><\/td>\r\n<\/tr>\r\n<tr>\r\n<td><strong>\ud83c\uddf7\ud83c\uddf4 Romania<\/strong><\/td>\r\n<td>High<\/td>\r\n<td>New 2026 CMR Code: advertising must be \"exclusively informative\"; physician image tied to discounts is expressly banned.<\/td>\r\n<td><a href=\"\/medical-compliance\/romania-medical-advertising\/\">Romania rules \u2192<\/a><\/td>\r\n<\/tr>\r\n<tr>\r\n<td><strong>\ud83c\uddec\ud83c\udde7 United Kingdom<\/strong><\/td>\r\n<td>High<\/td>\r\n<td>CAP + MHRA + CMA; direct fines up to 10% of global turnover; naming Botox or weight-loss injections in public ads is illegal.<\/td>\r\n<td><a href=\"\/medical-compliance\/united-kingdom-medical-advertising\/\">UK rules \u2192<\/a><\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<!-- ========== COMING SOON ========== -->\r\n<h2>More markets in progress<\/h2>\r\nGuides for <strong>Slovakia, Italy, Spain, and Ireland<\/strong> are in preparation. Advertising into a market not listed yet? It is still safer to assume the destination country's rules apply \u2014 reach out and we can prioritise it.\r\n<div class=\"msf-disclaimer\">\r\n\r\n<strong>Legal disclaimer:<\/strong> This hub and the guides it links to provide general information about European medical advertising regulations for educational purposes only and do not constitute legal advice. Regulations change and are enforced nationally. Verify all requirements with a qualified legal professional in the relevant jurisdiction before publishing any marketing materials. MedicalServiceFinder.com accepts no liability for decisions made based on this content.\r\n\r\nLast updated: July 2026 | Coverage: DE, AT, CH, FR, BE, NL, HU, PL, RO, UK \u2014 expanding.\r\n\r\n<\/div>\r\n<!-- \/.msf-compliance-page -->","link":"https:\/\/medicalservicefinder.com\/it\/medical-compliance\/","name":"European Medical Marketing Compliance: The Rules, Country by Country","slug":"medical-compliance","taxonomy":"category","parent":0,"meta":[],"acf":[],"_links":{"self":[{"href":"https:\/\/medicalservicefinder.com\/it\/wp-json\/wp\/v2\/categories\/757","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicalservicefinder.com\/it\/wp-json\/wp\/v2\/categories"}],"about":[{"href":"https:\/\/medicalservicefinder.com\/it\/wp-json\/wp\/v2\/taxonomies\/category"}],"wp:post_type":[{"href":"https:\/\/medicalservicefinder.com\/it\/wp-json\/wp\/v2\/posts?categories=757"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}